SelankSK5

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Cognitive & Neuro Research

Selank

Anxiety- and stress-related behavior

Selank specifications and reference prices. Select a specification to add it to your cart.

5mg/vial x 10vials
Reference priceUS$90.91

For laboratory research only. Not for human or veterinary use.

COA 检测报告 / Reports

Compare all specifications & reference prices
SKUSpecification / packReference price (USD)
SK55mg/vial x 10vialsUS$90.91
SK1010mg/vial x 10vialsUS$130.30

Temporarily sold-out specifications can still be added to an inquiry to ask about restocking. An inquiry is not an order or an agreed price.

RESEARCH FOCUS

Main Uses & FAQs

This page organizes directly related information on Selank regarding anxiety and stress-related behaviors. First, look at research questions and findings, then verify the population or species, study formulations, and scope of interpretation.

Main TopicsAnxiety · Stress-related behaviors
USAGE REFERENCE

Selank · Usage reference (for research purposes)

The following presents common research-context references for reconstitution, storage, dosage and cycles. The following presents common references in research settings. This page does not constitute advice for use in humans or animals.

🧪Reconstitution

Suggested Diluent
Bacteriostatic Water (containing 0.9% benzyl alcohol); some peptides may use sterile water or acetic acid to aid dissolution. See the individual product descriptions.
Diluent Volume
Slowly introduce the diluent along the vial wall until the lyophilized powder is covered. A common example is 5 mg reconstituted with 2 mL of bacteriostatic water, yielding approximately 2.5 mg/mL. Referenced reconstitution volumes are approximately 1–2.5 mL, with 2 mL commonly used. It is suggested to select and record a fixed volume based on the COA supplied with the purchase.
Handling Notes
Introduce the diluent slowly along the vial wall rather than directly onto the lyophilized powder. Leave it for 60–90 seconds to dissolve naturally; do not shake vigorously.

💾Storage

Unreconstituted Lyophilized Powder
Refrigerate at 2–8°C, protected from light; avoid repeated freeze–thaw cycles.
After Reconstitution
Refrigerate at 2–8°C; a common recommendation is touse within 28 days; do not freeze.
Transport
For short periods, use insulated packaging with ice packs; avoid high temperatures and direct light.

📏Dosage Reference (Research)

Purpose / SettingCommon Reference
ReferenceSubcutaneous Injection Reference

🔁Cycle

Intranasal administration, according to the protocol cycle.

View the Complete Usage Guide Library →

Note: The above describes common research-context references, rather than clinical recommendations. Refer to the batch COA and research protocol. For research use only; not for human or animal use.

Research SummaryKey Findings

What research findings exist for Selank regarding anxiety and stress-related behaviors?

Anxiety behavior improvement observed under specific stress conditions, more pronounced when combined in chronic stress models. Another study reports: some symptom improvements occurred earlier with combined treatment, and health-related quality of life and tolerance indicators show research significance.[1] ↗ [2] ↗

Before ReadingStudy populations, species, formulations and delivery conditions each have a defined scope. Research on an ingredient does not establish that this site's product batches have been validated for efficacy in humans or veterinary use.
4 Main ReferencesSorted by First Publication Date ↓
Animal Study2017 · Historical basic researchREF. 01

How do anxiety behaviors change under stress conditions?

Research Findings

Anxiety behavior improvement observed under specific stress conditions, more pronounced when combined in chronic stress models.[1] ↗

Study Design

Rat anxiety behavior model; Selank alone and combined with diazepam

Scope & Limitations

Different emotional situations lead to different results; it is not a verification of human efficacy; conditions and combined interventions cannot be ignored.

View the Article Title and Full Citation+

Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats.

Kasian A, Kolomin T, Andreeva L, Bondarenko E, Myasoedov N, Slominsky P, Shadrina M

Behavioural Neurology · Volume/Issue Year 2017
First published 2017-01-01 · PMID 28280289
DOI 10.1155/2017/5091027

Human Study2015 · Historical basic researchREF. 02

What was observed with the combined regimen including Selank?

Research Findings

Some symptom improvements from combination therapy appear earlier; quality of life and tolerance-related indicators indicate research significance.[2] ↗

Study Design

70 patients with anxiety-related disorders; Selank plus phenazepam compared with monotherapy.

Scope & Limitations

Part of a combination regimen, cannot attribute all benefits to Selank monotherapy; historical study in 2015.

View the Article Title and Full Citation+

[Optimization of the treatment of anxiety disorders with selank].

Medvedev VE, Tereshchenko ON, Kost NV, Ter-Israelyan AY, Gushanskaya EV, Chobanu IK, Sokolov OY, Myasoedov NF

Journal of Neurology and Psychiatry named after S.S. Korsakov · Volume/Issue Year 2015
First published on 2015-01-01 · PMID 26356395
DOI 10.17116/jnevro20151156133-40

Human Study2014 · Historical basic researchREF. 03

How should the anxiety studies of Selank compared to other drugs be interpreted?

Research Findings

The study reports Selank has anti-anxiety effects and partial quality of life improvement.[3] ↗

Study Design

60 patients with anxiety/somatic symptom disorder; Selank compared with phenazepam.

Scope & Limitations

Smaller historical comparative studies; cannot replace modern large-scale placebo-controlled validation.

View the Article Title and Full Citation+

[A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders].

Medvedev VE, Tereshchenko ON, Israelian AIu, Chobanu IK, Kost NV, Sokolov OIu, Miasoedov NF

Journal of Neurology and Psychiatry named after S.S. Korsakov · Volume/Issue Year 2014
First published on 2014-01-01 · PMID 25176261
DOI not provided in the database

Human Study2008 · Historical basic researchREF. 04

What was observed in studies of early anxiety patients?

Research Findings

Both groups had similar anti-anxiety effects, and Selank also showed some observations related to anti-fatigue.[4] ↗

Study Design

62 patients with generalized anxiety or neurasthenia; Selank compared with medazepam.

Scope & Limitations

2008 historical research; specific patients and comparative drugs, not equivalent to common stress-relief effects in healthy people.

View the Article Title and Full Citation+

[Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia].

Zozulia AA, Neznamov GG, Siuniakov TS, Kost NV, Gabaeva MV, Sokolov OIu, Serebriakova EV, Siranchieva OA, Andriushenko AV, Telesheva ES, Siuniakov SA, Smulevich AB, Miasoedov NF, Seredenin SB

Journal of Neurology and Psychiatry named after S.S. Korsakov · Volume/Issue Year 2008
First published 2008-01-01 · PMID 18454096
DOI not provided in the database

i

Currently, 4 original studies related to the theme of this page have been selected. The number of studies includes different designs, populations, or preparations, not commercial clinical efficacy ratings. This page is a usage-oriented positive data selection, not a systematic review or dosing recommendation. Historical studies, combination preparations, and special models are all separately indicated.

GO DEEPER

What Questions Do These Studies Address?

Compare study populations, findings and scope.

↗
QUESTIONS, ANSWERED

Selank · Frequently Asked Questions.

What research findings exist for Selank regarding anxiety and stress-related behaviors?+

Anxiety behavior improvement observed under specific stress conditions, more pronounced when combined in chronic stress models. Another study reports: some symptom improvements occurred earlier with combined treatment, and health-related quality of life and tolerance indicators show research significance.[1] ↗ [2] ↗

Do human studies of Selank include monotherapy or combination regimens?+

Both have. Some historical studies compared Selank with anti-anxiety drugs, and others added benzodiazepines. Benefits of combination regimens cannot be fully attributed to Selank monotherapy.[3] ↗ [2] ↗

Selank—these conclusions apply to which study populations?+

Rat anxiety behavior model; Selank alone and combined with diazepam; 70 patients with anxiety-related disorders; comparison of Selank plus phenazepam and alone; 60 patients with anxiety/somatoform disorders; comparison of Selank and phenazepam. Different stress scenarios yield different results; not verification of human efficacy; cannot ignore conditions and combined interventions.[1] ↗ [2] ↗ [3] ↗

VENTRO PEPTIDES & BIOTECH · RESEARCH PRODUCT RETAIL

Research peptides. Shop by product.

Compare specifications, reference prices and COA reports. Add products to your cart to request a quote.

Ventro Peptides & Biotech Logo
QUALITY DOCUMENTSCOA BY PRODUCTGLOBAL DELIVERYTECHNICAL SUPPORT

01 / CATALOG

Browse products

7 products Product names, specifications, and prices follow the current quotation
SemaglutideSM10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Semaglutide

10mg/vial x 10vials

US$90.91
TirzepatideTR20COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Tirzepatide

20mg/vial x 10vials

US$160.61
RetatrutideRT10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Retatrutide

10mg/vial x 10vials

US$109.09
BPC157BC10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Repair & Recovery Research

BPC157

10mg/vial x 10vials

US$133.33
MOTS-CMS20COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Longevity & Mitochondrial Research

MOTS-C

20mg/vial x 10vials

US$257.58
LiraglutideLR10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Liraglutide

10mg*10vials

US$164.71
IGF-lr3IG1COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Growth Hormone & IGF-1

IGF-lr3

1mg/vial x 10vials

US$505.88

03 / ABOUT VENTRO

Reliable peptide supply, built for long-term partnerships.

Ventro supports research product retail purchases with clear pack specifications, available quality documents, and responsive international support.

  • High-purity peptides
  • Available COA reports
  • COA & quality documentation
  • Flexible small-quantity purchases
  • Reliable global fulfillment
  • Research product retail support

04 / QUALITY SYSTEM

Quality without compromise

Browse the available COA reports by product. Confirm documentation for your order with our team.

Controlled quality workflowRaw material to final release
Responsive global supportProduct matching and technical support

RESEARCH PRODUCT INQUIRY

Submit a product inquiry

Tell us the product, specification, and expected quantity. Our team will respond with pricing and available documents.

Use another email app

Opening an inquiry creates a draft, not a sent message. Review and press Send in Gmail, WhatsApp or your email app. Opening a channel passes the draft to the chosen provider. Privacy & cookies

Contact Ventro

Choose a channel to contact the Ventro team directly.

Use another email app

Opening an inquiry creates a draft, not a sent message. Review and press Send in Gmail, WhatsApp or your email app. Opening a channel passes the draft to the chosen provider. Privacy & cookies

WhatsApp